Detalhe da pesquisa
1.
The phase I/II eNRGy trial: Zenocutuzumab in patients with cancers harboring NRG1 gene fusions.
Future Oncol
; 20(16): 1057-1067, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38348690
2.
Microtransplantation in older patients with AML: A pilot study of safety, efficacy and immunologic effects.
Am J Hematol
; 95(6): 662-671, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32162718
3.
A multi-institutional analysis of peritransplantation radiotherapy in patients with relapsed/refractory Hodgkin lymphoma undergoing autologous stem cell transplantation.
Cancer
; 123(8): 1363-1371, 2017 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27984652
4.
Management of chronic lymphocytic leukemia (CLL) in the era of B-cell receptor signal transduction inhibitors.
Am J Hematol
; 90(7): 657-64, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25808792
5.
Calcium/Calmodulin Dependent Protein Kinase Kinase 2 Regulates the Expansion of Tumor-Induced Myeloid-Derived Suppressor Cells.
Front Immunol
; 12: 754083, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34712241
6.
PET/CT in the Evaluation of Relapsed or Refractory Hodgkin Lymphoma.
Am J Hematol Oncol
; 12(9): 8-13, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29449908
7.
A Complete Response After Pseudo-progression: Pembrolizumab for Metastatic Squamous Cell Carcinoma (SCC) of the Bladder.
Clin Genitourin Cancer
; 17(3): e672-e677, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31097390